Inactive Instrument

Press Releases Renovacor, Inc.

Equities

RCOR

US75989E1064

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

RENOVACOR, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-11-10	AQ
RENOVACOR, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-10-14	AQ
Renovacor Announces Upcoming Presentation at the 29th European Society of Gene and Cell Therapy Congress	22-10-11	AQ
Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress	22-10-10	BU
Renovacor Announces Upcoming Presentation at Keystone Symposia's Heart Failure, Mechanisms and Therapies Conference	22-09-27	AQ
Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference	22-09-26	BU
RENOVACOR, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-09-22	AQ
RENOVACOR, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	22-09-20	AQ
Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy	22-09-20	BU
Renovacor : Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Form 8-K	22-08-08	PU
RENOVACOR, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-08-08	AQ
Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update	22-08-08	BU
RENOVACOR, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-07-12	AQ
Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy	22-07-12	BU
RENOVACOR, INC. Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K/A)	22-06-24	AQ
RENOVACOR, INC. : Change in Directors or Principal Officers (form 8-K)	22-06-03	AQ
RENOVACOR, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	22-06-01	AQ
Renovacor Announces Data from Pilot Pig Study Showing Successful Cardiac Transduction with REN-001 Delivered Via Low-Dose Retrograde Coronary Sinus Infusion Published in Journal of the American College of Cardiology: Basic to Translational Research	22-06-01	BU
RENOVACOR, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-05-26	AQ
Renovacor Reports First Quarter 2022 Financial Results and Provides Corporate Update	22-05-12	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Renovacor, Inc.

Equities

RCOR

US75989E1064

Press Releases

Filters